Active — Not RecruitingNot Applicable

Electromagnetic Transduction Therapy on Osteoarthritis in the Foot and Ankle

United States20 participantsStarted 2025-03-13

Plain-language summary

The purpose of this study is to determine if Electromagnetic Transduction Therapy (EMTT) is a viable treatment option in patients with osteoarthritis of the foot and/or ankle.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: • Men and women with osteoarthritis of the foot and/or ankle confirmed via radiographs. Exclusion Criteria: • Pacemaker, active cancer, shrapnel, metal in eye, implantable devices that are not compatible with MRIs, concurrent foot or ankle condition or injury, prior foot or ankle surgery for osteoarthritis, steroid, platelet rich plasma, or hyaluronic acid injection within 2 months of the treatment.

What they're measuring

Visual Analog Scale (VAS) for Pain

Timeframe: Baseline, 3 weeks, 3 months, 6 months

Foot and Ankle Ability Measure (FAAM)

Timeframe: Baseline, 3 weeks, 3 months, 6 months

Trial details

NCT IDNCT06696118

SponsorMayo Clinic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-03

View on ClinicalTrials.gov More Osteoarthritis Ankle trials